Equipped with automatic transport functionality! A CO2 incubator that solves various problems such as cell mix-ups.
Introducing the 'AC408xy' equipped with an automatic transport function that can be connected to an isolator. Traditionally, cell culture for multiple donors required a small incubator for each donor, which posed significant challenges in terms of space and cost when expanding facilities. This product aims to reduce space by automatically transporting and storing multiple independent chambers connected to the isolator, thereby preventing cross-contamination within the chamber and avoiding cell mix-ups. 【Features】 - Automatic transport between the incubator and the isolator - Capable of storing multiple independent chambers - Solves various issues such as cross-contamination and cell mix-ups *For more details, please refer to the PDF document or feel free to contact us.
Inquire About This Product
basic information
【Specifications】 ■Main unit dimensions: W1160×D1150×H2200(mm) ■Weight: 250kg ■Power supply voltage: 1φ2W AC200V 8.0kVA 40A ■External outputs: RS-485×1 / Ethernet×1 / FL-net×1 ■Control method: Digital PID control ■Control range: Room temperature +8℃ to +30℃ (maximum 50℃) *Note: Room temperature is 22.0 to 25.0℃ *For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
BioMedica Solutions Co., Ltd. is a company formed through collaboration between Panasonic Healthcare Co., Ltd. (formerly Sanyo Electric Co., Ltd. BioMedica Division), a top manufacturer of cell culture processing facilities and equipment, and Terra Co., Ltd., which possesses cell culture technology, know-how, and the largest track record of human cell culture in Japan. We aim to provide the latest cell culture technology and management know-how, contributing to the realization of regenerative medicine and cell therapy, and striving for a society where many people can safely receive cell therapy.